Literature DB >> 17435635

Executive summary of the African-American Initiative.

Clyde W Yancy1.   

Abstract

The roundtable discussion, "Managing Cardiovascular Disease in African Americans: Emerging Strategies for Optimizing Care, " was convened to review the evidence that supports best practices for the management of cardiovascular disease and its complications in African Americans. Treatment guidelines are reviewed, as is the clinical evidence supporting the use of diuretics, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and beta-blockers. The ultimate goals of this work are to improve the understanding of the links among hypertension, diabetes, the metabolic syndrome, and cardiovascular disease, all of which disproportionately affect African Americans, and to increase physician awareness of the unique impact of these conditions in the often underserved African-American population.

Entities:  

Mesh:

Year:  2007        PMID: 17435635      PMCID: PMC1925009     

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


  48 in total

1.  Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.

Authors:  Janice G Douglas; George L Bakris; Murray Epstein; Keith C Ferdinand; Carlos Ferrario; John M Flack; Kenneth A Jamerson; Wendell E Jones; Julian Haywood; Randall Maxey; Elizabeth O Ofili; Elijah Saunders; Ernesto L Schiffrin; Domenic A Sica; James R Sowers; Donald G Vidt
Journal:  Arch Intern Med       Date:  2003-03-10

2.  Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction.

Authors:  S S Gottlieb; R J McCarter; R A Vogel
Journal:  N Engl J Med       Date:  1998-08-20       Impact factor: 91.245

Review 3.  Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system.

Authors:  G M Reaven; H Lithell; L Landsberg
Journal:  N Engl J Med       Date:  1996-02-08       Impact factor: 91.245

4.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

5.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

6.  Low-dose combination therapy as first-line hypertension treatment for blacks and nonblacks.

Authors:  L M Prisant; J M Neutel; K Ferdinand; V Papademetriou; V DeQuattro; W D Hall; M R Weir
Journal:  J Natl Med Assoc       Date:  1999-01       Impact factor: 1.798

Review 7.  Drug treatment of hypertension complicating diabetes mellitus.

Authors:  M J MacLeod; J McLay
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

8.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

Authors:  Ihab Hajjar; Theodore A Kotchen
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

9.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

Authors:  Philip A Poole-Wilson; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Jacobus Lubsen; Beatrix Lutiger; Marco Metra; Willem J Remme; Christian Torp-Pedersen; Armin Scherhag; Allan Skene
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

10.  Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  M A Winkleby; H C Kraemer; D K Ahn; A N Varady
Journal:  JAMA       Date:  1998 Jul 22-29       Impact factor: 56.272

View more
  3 in total

1.  Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials.

Authors:  Megan E Piper; Jessica W Cook; Tanya R Schlam; Douglas E Jorenby; Stevens S Smith; Daniel M Bolt; Wei-Yin Loh
Journal:  Nicotine Tob Res       Date:  2010-05-03       Impact factor: 4.244

2.  Patient navigation to promote smoking cessation among low-income primary care patients: a pilot randomized controlled trial.

Authors:  Karen E Lasser; Karey S Kenst; Lisa M Quintiliani; Renda Soylemez Wiener; Jennifer Murillo; Lori Pbert; Ziming Xuan; Deborah J Bowen
Journal:  J Ethn Subst Abuse       Date:  2013       Impact factor: 1.507

3.  Clinical and genetic modifiers of long-term survival in heart failure.

Authors:  Sharon Cresci; Reagan J Kelly; Thomas P Cappola; Abhinav Diwan; Daniel Dries; Sharon L R Kardia; Gerald W Dorn
Journal:  J Am Coll Cardiol       Date:  2009-07-28       Impact factor: 24.094

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.